Abstract
Up-regulation of cyclooxygenase-2 occurs in retinal cells during the early onset of diabetic retinopathy. Under these conditions, prostaglandin production is elevated, which in turn leads to an increased expression of vascular endothelial growth factor (VEGF)--a growth factor implicated in vascular leakage and neovascularization. In this ex vivo study, we tested whether cyclooxygenase-1 or cyclooxygenase-2 is responsible for diabetes-induced secretion of prostaglandin E2 from isolated rat retinas. Celecoxib, a selective cyclooxygenase-2 inhibitor, significantly inhibited prostaglandin E2 secretion, whereas SC560 [5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethylpyrazole], a selective cyclooxygenase-1 inhibitor, had no inhibitory effect. These results suggests that the enzymatic activity of cyclooxygenase-2, but not cyclooxygenase-1, results in prostaglandin E2 secretion under diabetic conditions.
References
Jul 15, 1985·American Journal of Ophthalmology·N K SharmaD B Archer
Oct 1, 1966·Diabetes·E D Powell, R A Field
Feb 1, 1997·Prostaglandins, Leukotrienes, and Essential Fatty Acids·C FangD R Tomlinson
Mar 1, 1997·Diabetes/metabolism Reviews·J W MillerL P Aiello
May 1, 1999·Current Eye Research·E I JohnsonR G Larkins
Sep 15, 1999·Proceedings of the National Academy of Sciences of the United States of America·K MiyamotoA P Adamis
Jun 7, 2000·The Journal of Clinical Investigation·C S WilliamsR N DuBois
Jan 6, 2001·The American Journal of Pathology·A M JoussenA P Adamis
Feb 24, 2001·Mediators of Inflammation·A CarmoM C Lopes
Jun 26, 2001·Diabetes·T S Kern, R L Engerman
Mar 27, 2002·The British Journal of Ophthalmology·A P Adamis
Citations
Mar 1, 2012·Pflügers Archiv : European journal of physiology·Keiko IshidaTsuneo Kobayashi
Sep 24, 2008·Pharmaceutical Research·Soumyajit Majumdar, Ramesh Srirangam
Nov 7, 2008·Pharmaceutical Research·Narayan P S CheruvuUday B Kompella
Oct 1, 2013·Biochemical Pharmacology·Gabriella LupoClaudio Bucolo
Mar 5, 2013·The British Journal of Nutrition·Rantao ZuoWei Xu
Mar 22, 2008·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Zaher A Radi, James A Render
May 11, 2011·Immunotherapy·Wenbo ZhangRuth B Caldwell
Feb 16, 2008·Experimental Diabetes Research·Timothy S Kern
Mar 9, 2010·Expert Opinion on Drug Delivery·Aniruddha AmriteUday Kompella
Dec 3, 2008·Expert Opinion on Emerging Drugs·Quresh Mohamed, Tien Y Wong
May 6, 2015·International Journal of Molecular Medicine·Jianyan HuQiang Wu
Sep 1, 2015·Journal of the American Society of Nephrology : JASN·Rania NasrallahRichard L Hébert
Apr 20, 2010·Experimental Eye Research·Susan E YanniJohn S Penn
Jun 30, 2009·Progress in Retinal and Eye Research·Heping XuJohn V Forrester
May 19, 2009·European Journal of Pharmacology·Asami MoriKunio Ishii
Jun 16, 2009·Neurochemistry International·Belmira Lara da Silveira Andrade da CostaNeville N Osborne
Aug 25, 2015·Experimental Eye Research·Sumon RoySayon Roy
Feb 25, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·S S H ChenH Majewski
Mar 29, 2005·European Journal of Pharmacology·Surya P Ayalasomayajula, Uday B Kompella
Aug 8, 2015·Journal of Neuroinflammation·Ying YuShao Bo Su
May 6, 2014·International Journal of Cardiology·Igor V KizubAnatoly I Soloviev
Feb 24, 2009·Toxicologic Pathology·Zaher A Radi
Sep 10, 2020·Drug Delivery and Translational Research·Sherif A GaballaHamdy Abdelkader
Aug 8, 2020·Antioxidants·Beatriz MartinsRosa Fernandes
Aug 29, 2018·Diabetologia·Ghazaleh HajmousaMartin C Harmsen
Jun 19, 2007·Drugs & Aging·Shyam S BansalArvind K Bansal
Nov 30, 2020·Redox Biology·Qingzheng Kang, Chunxue Yang